342 related articles for article (PubMed ID: 19923896)
21. Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.
Guo X; Ramirez A; Waddell DS; Li Z; Liu X; Wang XF
Genes Dev; 2008 Jan; 22(1):106-20. PubMed ID: 18172167
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers.
Park HB; Kim JW; Baek KH
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486158
[TBL] [Abstract][Full Text] [Related]
23. Natural Functions of PLIN2 Mediating Wnt/LiCl Signaling and Glycogen Synthase Kinase 3 (GSK3)/GSK3 Substrate-Related Effects Are Modulated by Lipid.
Liu X; Lu X; Song K; Blackman MR
Mol Cell Biol; 2016 Feb; 36(3):421-37. PubMed ID: 26598603
[TBL] [Abstract][Full Text] [Related]
24. Mitotic wnt signaling promotes protein stabilization and regulates cell size.
Acebron SP; Karaulanov E; Berger BS; Huang YL; Niehrs C
Mol Cell; 2014 May; 54(4):663-74. PubMed ID: 24837680
[TBL] [Abstract][Full Text] [Related]
25. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
Schmitz Y; Rateitschak K; Wolkenhauer O
Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
[TBL] [Abstract][Full Text] [Related]
26. Regulated proteolytic processing of LRP6 results in release of its intracellular domain.
Mi K; Johnson GV
J Neurochem; 2007 Apr; 101(2):517-29. PubMed ID: 17326769
[TBL] [Abstract][Full Text] [Related]
27. Tumor Suppressor Lzap Suppresses Wnt/β-Catenin Signaling to Promote Zebrafish Embryonic Ventral Cell Fates via the Suppression of Inhibitory Phosphorylation of Glycogen Synthase Kinase 3.
Lin KY; Kao SH; Lai CM; Chen CT; Wu CY; Hsu HJ; Wang WD
J Biol Chem; 2015 Dec; 290(50):29808-19. PubMed ID: 26475862
[TBL] [Abstract][Full Text] [Related]
28. A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of beta-catenin/GSK3 signaling.
Klinghoffer RA; Frazier J; Annis J; Berndt JD; Roberts BS; Arthur WT; Lacson R; Zhang XD; Ferrer M; Moon RT; Cleary MA
PLoS One; 2009 Sep; 4(9):e6892. PubMed ID: 19727391
[TBL] [Abstract][Full Text] [Related]
29. Re-evaluating the role of Frat in Wnt-signal transduction.
van Amerongen R; Berns A
Cell Cycle; 2005 Aug; 4(8):1065-72. PubMed ID: 16082208
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells.
Failor KL; Desyatnikov Y; Finger LA; Firestone GL
Mol Endocrinol; 2007 Oct; 21(10):2403-15. PubMed ID: 17595317
[TBL] [Abstract][Full Text] [Related]
31. Measuring GSK3 expression and activity in cells.
Cole AR; Sutherland C
Methods Mol Biol; 2008; 468():45-65. PubMed ID: 19099245
[TBL] [Abstract][Full Text] [Related]
32. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
[TBL] [Abstract][Full Text] [Related]
33. Presenilin deficiency or lysosomal inhibition enhances Wnt signaling through relocalization of GSK3 to the late-endosomal compartment.
Dobrowolski R; Vick P; Ploper D; Gumper I; Snitkin H; Sabatini DD; De Robertis EM
Cell Rep; 2012 Nov; 2(5):1316-28. PubMed ID: 23122960
[TBL] [Abstract][Full Text] [Related]
34. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
35. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal.
Fuentealba LC; Eivers E; Ikeda A; Hurtado C; Kuroda H; Pera EM; De Robertis EM
Cell; 2007 Nov; 131(5):980-93. PubMed ID: 18045539
[TBL] [Abstract][Full Text] [Related]
36. MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.
Ploper D; Taelman VF; Robert L; Perez BS; Titz B; Chen HW; Graeber TG; von Euw E; Ribas A; De Robertis EM
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E420-9. PubMed ID: 25605940
[TBL] [Abstract][Full Text] [Related]
37. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin.
Thomas GM; Frame S; Goedert M; Nathke I; Polakis P; Cohen P
FEBS Lett; 1999 Sep; 458(2):247-51. PubMed ID: 10481074
[TBL] [Abstract][Full Text] [Related]
38. GSK3 Inhibits Macropinocytosis and Lysosomal Activity through the Wnt Destruction Complex Machinery.
Albrecht LV; Tejeda-Muñoz N; Bui MH; Cicchetto AC; Di Biagio D; Colozza G; Schmid E; Piccolo S; Christofk HR; De Robertis EM
Cell Rep; 2020 Jul; 32(4):107973. PubMed ID: 32726636
[TBL] [Abstract][Full Text] [Related]
39. The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity.
Mi K; Dolan PJ; Johnson GV
J Biol Chem; 2006 Feb; 281(8):4787-94. PubMed ID: 16365045
[TBL] [Abstract][Full Text] [Related]
40. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.
Haraguchi K; Ohsugi M; Abe Y; Semba K; Akiyama T; Yamamoto T
Oncogene; 2008 Jan; 27(3):274-84. PubMed ID: 17621269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
